2024-2032年全球醫療保健冷鏈物流市場報告及預測

2023年，全球醫療保健冷鏈物流市場規模達到176億美元。展望未來， IMARC Group預計到2032年市場規模將達到230億美元，2024-2032年複合年成長率（CAGR）為2.9%。對疫苗和生物製劑的需求不斷成長、對溫度敏感的醫療保健產品嚴格的監管要求和品質標準的實施以及製藥行業的快速成長是推動市場的一些主要因素。

醫療保健冷鏈物流是指在受控溫度範圍內處理、運輸和儲存對溫度敏感的藥品、疫苗和生物製劑的專門製程。在從製造到分銷直至最終用戶的整個供應鏈中，保持這些醫療產品的功效和安全性至關重要。冷鏈物流涉及使用冷藏或隔熱貨櫃、溫控倉庫和先進的監控技術，以確保產品保持在指定的溫度範圍內，防止溫度超出範圍而影響其品質和有效性。因此，這個關鍵系統在保障公眾健康和確保全球範圍內提供可靠的醫療保健產品方面發揮著至關重要的作用。

對溫度敏感的藥品、疫苗和生物製品的需求不斷成長，需要可靠、高效的冷鏈物流系統來維持產品的完整性和功效，這將刺激預測期內市場的成長。此外，由於製藥和生物技術行業的快速擴張，對專業溫控運輸和儲存解決方案的需求不斷增加，這對市場成長產生了積極影響。除此之外，全球突發衛生事件和疫苗接種計劃的增加，例如最近爆發的冠狀病毒（COVID-19）大流行期間，增加了對無縫醫療保健冷鏈物流的需求，以確保及時、安全地分發救生物資醫療產品。此外，醫療保健產品的多項嚴格監管要求和品質標準，包括良好分銷規範 (GDP) 指南，加速了專業冷鏈物流服務的採用，以遵守嚴格的處理和監控協議。此外，對通常對溫度敏感的個人化醫療和生物製藥的高度關注正在促進市場成長。

醫療保健冷鏈物流市場趨勢/促進因素：

對溫度敏感的醫療產品的需求不斷成長

全球對溫度敏感的藥品、疫苗和生物製品的需求增加推動了醫療保健冷鏈物流市場。隨著製藥和生物技術產業的不斷擴張和創新，更加需要可靠、高效的冷鏈系統來確保這些精緻醫療產品在運輸和儲存過程中的完整性和有效性。在整個供應鏈中保持受控的溫度範圍對於防止可能損害產品品質和有效性的溫度偏差至關重要。這導致對專業醫療保健冷鏈物流服務和技術的投資增加，以滿足不斷成長的需求並確保對溫度敏感的醫療保健產品的安全可靠的配送。

全球突發衛生事件和疫苗接種計畫不斷升級

流行病和疾病爆發等全球突發衛生事件的日益普遍，導致對醫療保健冷鏈物流的需求不斷增加。在這些危機期間，及時有效地分發疫苗、藥品和醫療用品對於遏制疾病傳播和保護公眾健康至關重要。有效的疫苗接種計劃依賴強大的醫療保健冷鏈物流系統，以確保疫苗從生產到管理的整個過程中保持其效力和功效。應對突發衛生事件和實施大規模疫苗接種活動的緊迫性凸顯了無縫冷鏈物流在醫療保健領域的至關重要性，凸顯了其對全球健康結果的影響。

實施嚴格的監管合規性和品質標準

醫療保健行業在嚴格的監管要求和品質標準下營運，以確保患者安全和產品功效。對於溫度敏感的醫療產品，遵守良好分銷規範 (GDP) 指南對於確保這些產品在指定的溫度範圍內儲存、運輸和處理至關重要。保持對這些法規的遵守要求醫療保健冷鏈物流流程具有高度的精確性和責任感。對滿足監管合規性的日益重視推動了對先進醫療保健冷鏈物流解決方案的需求，這些解決方案提供強大的監控、資料管理和驗證功能，以確保整個供應鏈的品質和合規性。

目錄

第1章：前言

第 2 章：範圍與方法

• 研究目的
• 利害關係人
• 資料來源
  • 主要資源
  • 二手資料
• 市場預測
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第 3 章：執行摘要

第 4 章：全球醫療保健冷鏈產品市場

• 歷史、當前和未來的市場趨勢
• 市場部門
  • 生物製藥
    • 歷史、當前和未來的市場趨勢
    • 生物製藥的冷鏈要求
    • 生物製藥的冷鏈機遇
  • 疫苗
    • 歷史、當前和未來的市場趨勢
    • 疫苗冷鏈要求
    • 疫苗的冷鏈機會
  • 臨床試驗材料
    • 歷史、當前和未來的市場趨勢
    • 臨床試驗材料冷鏈要求
    • 臨床試驗材料的冷鏈機會

第5章：醫療保健冷鏈物流服務市場

• 當前和歷史的市場趨勢
• COVID-19 的影響
• 市場區隔：按產品
  • 臨床試驗材料
  • 疫苗
  • 生物製藥
• 市場區隔：按細分市場
  • 運輸
    • 當前和歷史的市場趨勢
    • 市場區隔：依運輸類型
    • 市場預測
  • 包裝
    • 當前和歷史的市場趨勢
    • 市場區隔：依包裝類型
    • 市場預測
  • 儀器儀表
    • 當前和歷史的市場趨勢
    • 市場區隔：依儀器類型
    • 市場預測
• 市場：按地區
  • 北美洲
  • 歐洲
  • 亞太地區
  • 世界其他地區

第 6 章：價值鏈分析

• 藥品生產設施
• 冷藏倉庫
• 運輸（空運/海運/公路/鐵路）
• 配送中心
• 交通（公路）
• 終端用戶

第 7 章：價格分析

• 價格指標
• 價格結構
• 冷鏈物流服務成本對比非冷鏈物流服務

第 8 章：SWOT 分析

• 概述
• 優勢
• 弱點
• 機會
• 威脅

第 9 章：波特的五力分析

• 概述
• 買家的議價能力
• 供應商的議價能力
• 競爭程度
• 新進入者的威脅
• 替代品的威脅

第 10 章：醫療保健冷鏈物流：如何運作？

• 冷鏈包裝及運輸方式
  • 乾冰
  • 液態氮
  • 凝膠包
• 建立冷鏈
  • 初步考慮
  • 選擇正確的型號
  • 監管/清關
  • 最後階段
  • 品質保證

第 11 章：競爭格局

• 市場結構
• 關鍵參與者
• 關鍵參與者簡介
  • Amerisource Bergen Corporation (World Courier)
  • Deutsche Post DHL Group
  • FedEx Corporation Services, Inc.
  • United Parcel Service of America, Inc.
  • Kuehne + Nagel International AG, Cavalier Logistics, Inc.
  • DB Schenker
  • Life ConEx
  • American Airlines Cargo
  • Continental Group
  • Marken

Abstract

The global healthcare cold chain logistics market size reached US$ 17.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The increasing demand for vaccines and biologics, the implementation of stringent regulatory requirements and quality standards for temperature-sensitive healthcare products, and the rapid growth in the pharmaceutical industry are some of the major factors propelling the market.

Healthcare cold chain logistics refers to the specialized process of handling, transporting, and storing temperature-sensitive pharmaceuticals, vaccines, and biologics within a controlled temperature range. It is essential to maintain the efficacy and safety of these medical products throughout the supply chain, from manufacturing to distribution and ultimately to the end-user. Cold chain logistics involves the use of refrigerated or insulated containers, temperature-controlled warehouses, and advanced monitoring technologies to ensure that the products are kept within specified temperature ranges, protecting them from temperature excursions that could compromise their quality and effectiveness. As a result, this critical system plays a crucial role in safeguarding public health and ensuring the availability of reliable healthcare products across the globe.

The rising demand for temperature-sensitive pharmaceuticals, vaccines, and biologics that require a reliable and efficient cold chain logistics system to maintain product integrity and efficacy, will stimulate the growth of the market during the forecast period. Moreover, the escalating need for specialized temperature-controlled transportation and storage solutions due to the rapid expansion of the pharmaceutical and biotechnology industries is positively influencing the market growth. Apart from this, the increasing global health emergencies and vaccination programs, such as during the recent outbreak of the coronavirus (COVID-19) pandemic, has augmented the demand for seamless healthcare cold chain logistics to ensure the timely and safe distribution of life-saving medical products. Additionally, several stringent regulatory requirements and quality standards for healthcare products, including Good Distribution Practice (GDP) guidelines, has accelerated the adoption of specialized cold chain logistics services to comply with strict handling and monitoring protocols. Furthermore, the heightening focus on personalized medicine and biopharmaceuticals, which are often temperature-sensitive, is contributing to market growth.

Healthcare Cold Chain Logistics Market Trends/Drivers:

Growing demand for temperature-sensitive medical products

The market for healthcare cold chain logistics is fueled by an increase in the demand for temperature-sensitive pharmaceuticals, vaccines, and biologics worldwide. As the pharmaceutical and biotechnology industries continue to expand and innovate, there is a greater need for a reliable and efficient cold chain system to ensure the integrity and efficacy of these delicate medical products during transportation and storage. Maintaining a controlled temperature range throughout the supply chain is crucial to prevent temperature excursions that could compromise the quality and effectiveness of the products. This has led to a rise in investment in specialized healthcare cold chain logistics services and technologies to meet the growing demand and ensure the safe and reliable distribution of temperature-sensitive healthcare products.

Escalating global health emergencies and vaccination programs

The increasing prevalence of global health emergencies, such as pandemics and disease outbreaks, are contributing to the high demand for healthcare cold chain logistics. During these crises, the timely and efficient distribution of vaccines, pharmaceuticals, and medical supplies becomes crucial to curb the spread of diseases and protect public health. Effective vaccination programs rely on a robust healthcare cold chain logistics system to ensure that vaccines maintain their potency and efficacy from manufacturing to administration. The urgency to respond to health emergencies and implement large-scale vaccination campaigns highlights the critical importance of seamless cold chain logistics in the healthcare sector, underscoring its impact on global health outcomes.

Implementation of stringent regulatory compliance and quality standards

The healthcare industry operates under stringent regulatory requirements and quality standards to ensure patient safety and product efficacy. For temperature-sensitive medical products, adherence to Good Distribution Practice (GDP) guidelines is essential to guarantee that these products are stored, transported, and handled within the specified temperature ranges. Maintaining compliance with these regulations demands a high level of precision and accountability in healthcare cold chain logistics processes. The increase in emphasis on meeting regulatory compliance propels the demand for advanced healthcare cold chain logistics solutions that offer robust monitoring, data management, and validation capabilities to ensure quality and conformity throughout the supply chain.

Healthcare Cold Chain Logistics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global healthcare cold chain logistics market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product and segment.

Breakup by Product:

Clinical Trial Materials

Vaccines

Biopharmaceuticals

Vaccines dominate the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes clinical trial materials, vaccines, and biopharmaceuticals. According to the report, vaccines represented the largest segment.

Vaccines play a central role as critical tools for preventing and controlling infectious diseases. They require stringent temperature control to maintain their potency and efficacy. The need for a robust cold chain is essential from the manufacturing stage to delivery to end-users, such as healthcare facilities and vaccination centers. Healthcare cold chain logistics ensures that vaccines are stored, transported, and handled within specified temperature ranges, safeguarding their integrity and effectiveness.

Moreover, the constant demand for vaccines, particularly during global health emergencies and vaccination programs, puts immense pressure on the healthcare cold chain logistics system to ensure timely and safe distribution. To meet this challenge, logistics providers are investing in specialized infrastructure, real-time monitoring technologies, and stringent quality control processes to maintain the cold chain's integrity and support the efficient delivery of vaccines, ultimately contributing to global health and disease prevention efforts, thus driving the growth of the vaccine segment.

Breakup by Segment:

Global Healthcare Cold Chain Logistics Market Share, By Segment (in %)

Transportation

Packaging

Instrumentation

20%

30%

50%

imarcgroup.com

Transportation 50

Packaging 30

Instrumentation 20

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Transportation

Packaging

Instrumentation

Packaging holds the largest share in the market

A detailed breakup and analysis of the market based on the segment has also been provided in the report. This includes transportation, packaging, and instrumentation. According to the report, packaging accounted for the largest market share.

The safe and effective transportation of temperature-sensitive medical products heavily relies on specialized packaging solutions that maintain product integrity throughout the supply chain. Packaging ensures that pharmaceuticals, vaccines, and biologics are insulated from temperature excursions, protecting them from degradation and maintaining their efficacy. Advanced thermal protection materials, insulated containers, and temperature-monitoring devices are incorporated into healthcare cold chain packaging to provide a controlled environment and real-time visibility during transportation and storage.

Packaging innovations enable longer shelf life, enhanced stability, and reduced risk of spoilage for temperature-sensitive healthcare products, facilitating their safe distribution to end users. As the demand for temperature-sensitive medical products continues to rise, the market for healthcare cold chain logistics invests in cutting-edge packaging technologies and solutions to ensure the safe and reliable delivery of medical products, contributing significantly to patient safety and public health.

Breakup by Region:

North America

Europe

Asia Pacific

Rest of the world

Asia Pacific exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, and Rest of the World. According to the report, Asia Pacific was the largest regional market for healthcare cold chain logistics.

Asia Pacific held the biggest share in the market since the region is witnessing substantial population growth and increasing levels of urbanization, leading to a rise in demand for temperature-sensitive medical products, such as vaccines and biologics, to cater to the healthcare needs of its vast population.

Additionally, the prevalence of infectious diseases and the occurrence of health emergencies necessitate efficient cold chain logistics to ensure timely and safe distribution of medical supplies and vaccines. The region's thriving pharmaceutical and biotechnology industries also fuels the demand for specialized healthcare cold chain services to maintain the integrity and efficacy of medical products during transportation and storage. The increasing investment in upgrading the healthcare infrastructure across the Asia Pacific region, continuous technological advancements by regional industry players, and stringent regulatory compliance further supports the expansion of the market, driving its importance in the region's healthcare ecosystem.

Competitive Landscape:

The market is experiencing steady growth as various key players operating in the healthcare cold chain logistics industry have made significant contributions by providing specialized and reliable solutions to address the unique challenges of transporting temperature-sensitive medical products. Manufacturers are heavily investing in advanced technologies and infrastructure to ensure seamless temperature control throughout the supply chain. They are also offering temperature-monitored storage facilities, refrigerated transportation, and real-time monitoring systems to maintain product integrity and compliance with strict regulatory requirements. Vendors also play a crucial role in implementing innovative packaging solutions and thermal protection materials to safeguard the products from temperature excursions during transit. Additionally, they contribute to the market growth by providing specialized training and expertise to ensure the proper handling and distribution of temperature-sensitive healthcare products, ultimately supporting the healthcare industry in delivering safe and effective medical treatments to patients across the globe. We also expect the market to witness a rise in strategic collaborations and partnerships amongst key players, continual product innovations, and technological advancements to drive healthy competition within the domain.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amerisource Bergen Corporation (World Courier)

Deutsche Post DHL Group

FedEx Corporation Services, Inc.

United Parcel Service of America, Inc.

Kuehne + Nagel International AG

Cavalier Logistics, Inc.

DB Schenker

Life ConEx

American Airlines Cargo

Continental Group

Marken Ltd.

Recent Developments:

In December 2020, FedEx Corp, a leading logistics company, completed the acquisition of ShopRunner, a technology platform that connects retailers with online shoppers. This strategic move is expected to enhance the company's e-commerce capabilities significantly, empowering it to offer a more comprehensive and efficient logistics solution to its customers. With ShopRunner's expertise in online retail and customer engagement, FedEx can bolster its presence in the rapidly growing e-commerce market.

In December 2022, Kuehne+Nagel International AG, a renowned global logistics company, announced a significant milestone by entering into an agreement for the development of a state-of-the-art healthcare logistics focused airside facility in South Africa. This strategic move reflects the company's commitment to meeting the increasing demand for specialized cold chain logistics solutions in the healthcare sector. The new airside facility will be strategically located at an airport in South Africa, facilitating seamless and expedited transportation of temperature-sensitive medical products, including pharmaceuticals, vaccines, and biologics.

In February 2022, Cavalier Logistics UK, a prominent player in the logistics industry, has taken significant steps to bolster its presence across Europe. Through a strategic expansion initiative, the company has extended its footprint in various major European markets. This expansion comes as a testament to their commitment to improving their logistics capabilities and reach within the region. This move allows them to tap into new opportunities and serve a broader customer base while positioning themselves as a leading force in the European logistics landscape.

Key Questions Answered in This Report

• 1. What was the size of the global healthcare cold chain logistics market in 2023?
• 2. What is the expected growth rate of the global healthcare cold chain logistics market during 2024-2032?
• 3. What are the key factors driving the global healthcare cold chain logistics market?
• 4. What has been the impact of COVID-19 on the global healthcare cold chain logistics market?
• 5. What is the breakup of the global healthcare cold chain logistics market based on the product?
• 6. What is the breakup of the global healthcare cold chain logistics market based on the segment?
• 7. What are the key regions in the global healthcare cold chain logistics market?
• 8. Who are the key players/companies in the global healthcare cold chain logistics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 The Global Healthcare Cold Chain Products Market

• 4.1 Historical, Current and Future Market Trends
• 4.2 Market Segments
  • 4.2.1 Biopharmaceuticals
    • 4.2.1.1 Historical, Current and Future Market Trends
    • 4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
    • 4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
  • 4.2.2 Vaccines
    • 4.2.2.1 Historical, Current and Future Market Trends
    • 4.2.2.2 Cold Chain Requirements for Vaccines
    • 4.2.2.3 Cold Chain Opportunities for Vaccines
  • 4.2.3 Clinical Trial Materials
    • 4.2.3.1 Historical, Current and Future Market Trends
    • 4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
    • 4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials

5 Healthcare Cold Chain Logistic Services Market

• 5.1 Current and Historical Market Trends
• 5.2 Impact of COVID-19
• 5.3 Market Breakup by Product
  • 5.3.1 Clinical Trial Materials
  • 5.3.2 Vaccines
  • 5.3.3 Biopharmaceuticals
• 5.4 Market Breakup by Segment
  • 5.4.1 Transportation
    • 5.4.1.1 Current and Historical Market Trends
    • 5.4.1.2 Market Breakup by Transportation Type
    • 5.4.1.3 Market Forecast
  • 5.4.2 Packaging
    • 5.4.2.1 Current and Historical Market Trends
    • 5.4.2.2 Market Breakup by Packaging Type
    • 5.4.2.3 Market Forecast
  • 5.4.3 Instrumentation
    • 5.4.3.1 Current and Historical Market Trends
    • 5.4.3.2 Market Breakup by Instrumentation Type
    • 5.4.3.3 Market Forecast
• 5.5 Market by Region
  • 5.5.1 North America
  • 5.5.2 Europe
  • 5.5.3 Asia Pacific
  • 5.5.4 Rest of the World

6 Value Chain Analysis

• 6.1 Drug Production Facility
• 6.2 Refrigerated Warehouse
• 6.3 Transport (Air/Sea/Road/Rail)
• 6.4 Distribution centres
• 6.5 Transport (Road)
• 6.6 End Users

7 Price Analysis

• 7.1 Price Indicators
• 7.2 Price Structure
• 7.3 Cost of Cold Chain Logistic Services Vs. Non-Cold Chain Logistic Services

8 SWOT Analysis

• 8.1 Overview
• 8.2 Strengths
• 8.3 Weaknesses
• 8.4 Opportunities
• 8.5 Threats

9 Porter's Five Forces Analysis

• 9.1 Overview
• 9.2 Bargaining Power of Buyers
• 9.3 Bargaining Power of Suppliers
• 9.4 Degree of Competition
• 9.5 Threat of New Entrants
• 9.6 Threat of Substitutes

10 Healthcare Cold Chain Logistics: How Does It Operate?

• 10.1 Cold Chain Packaging and Transportation Methods
  • 10.1.1 Dry Ice
  • 10.1.2 Liquid Nitrogen
  • 10.1.3 Gel Packs
• 10.2 Setting Up a Cold Chain
  • 10.2.1 Initial Considerations
  • 10.2.2 Choosing the Correct Model
  • 10.2.3 Regulatory/Custom Clearance
  • 10.2.4 Final Stages
  • 10.2.5 Quality Assurance

11 Competitive Landscape

• 11.1 Market Structure
• 11.2 Key Players
• 11.3 Profiles of Key Players
  • 11.3.1 Amerisource Bergen Corporation (World Courier)
  • 11.3.2 Deutsche Post DHL Group
  • 11.3.3 FedEx Corporation Services, Inc.
  • 11.3.4 United Parcel Service of America, Inc.
  • 11.3.5 Kuehne + Nagel International AG, Cavalier Logistics, Inc.
  • 11.3.6 DB Schenker
  • 11.3.7 Life ConEx
  • 11.3.8 American Airlines Cargo
  • 11.3.9 Continental Group
  • 11.3.10 Marken

List of Figures

• Figure 1: Global: Healthcare Cold Chain Products Market: Breakup by Segment (in %), 2018-2023
• Figure 2: Global: Healthcare Cold Chain Products Market Forecast: Breakup by Segment (in Million US$), 2024-2032
• Figure 3: Global: Biopharmaceutical Market (in Billion US$), 2018-2023
• Figure 4: Global: Biopharmaceutical Market Forecast (in Billion US$), 2024-2032
• Figure 5: Global: Biosimilar Sales and (in Billion US$), 2023 & 2032
• Figure 6: Global: Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2018-2023
• Figure 7: Global: Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2024-2032
• Figure 8: Global: Vaccine Market (in Billion US$), 2018-2023
• Figure 9: Global: Vaccine Market Forecast (in Billion US$), 2024-2032
• Figure 10: Global: Healthcare Cold Chain Logistic Services Market: Breakup by Region (in %), 2023
• Figure 11: Global: Vaccine Production Volume by Region (in %)
• Figure 12: Europe: Vaccine Export Volume by Region (in %)
• Figure 13: Global: Clinical Trials Market (in Billion US$), 2018-2023
• Figure 14: Global: Clinical Trials Market - Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2018-2023
• Figure 15: Time Taken for Biopharmaceuticals to Get Approved (in Months)
• Figure 16: Global: Clinical Trials Market Forecast (in Billion US$), 2024-2032
• Figure 17: Global: Clinical Trials Market Forecast: Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$) 2024-2032
• Figure 18: Global: Breakup of Biopharmaceuticals and Small Molecule Drugs in Preclinical & Clinical trials, (in %) 2023
• Figure 19: Top Reasons for Conducting Clinical Trials in Each Country (in %)
• Figure 20: Global: Healthcare Cold & Non-Cold Chain Products Market (in Billion US$), 2018-2023
• Figure 21: Global: Healthcare Cold & Non-Cold Chain Products Market Forecast (in Billion US$), 2024-2032
• Figure 22: Global: Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
• Figure 23: Global: Contract Research & Manufacturing Market (in Billion US$), 2018-2023
• Figure 24: Global: Contract Research & Manufacturing Market Forecast (in Billion US$), 2024-2032
• Figure 25: Estimated Costs incurred in Various Pharmaceutical Operations
• Figure 26: A Typical Drug Supply Chain from the Manufacturer to the End User
• Figure 27: Global: Healthcare Cold Chain Logistic Services Market: Value Trends (in Billion US$), 2018-2023
• Figure 28: Global: Healthcare Non-Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 29: Global: Healthcare Logistic Services Market: Share of Cold-Chain and Non-Cold Chain Services (in %), 2023
• Figure 30: Global: Healthcare Cold Chain Logistic Services Market Forecast: Value Trends (in Billion US$), 2024-2032
• Figure 31: Global: Healthcare Non-Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 32: Global: Healthcare Logistic Services Market Forecast: Share of Cold-Chain and Non-Cold Chain Services (in %), 2032
• Figure 33: Global: Healthcare Cold Chain Logistic Services Market by Product (in %), 2023 & 2032
• Figure 34: Global: Clinical Trial Materials Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 35: Global: Clinical Trial Materials Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 36: Global: Vaccines Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 37: Global: Vaccines Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 38: Global: Biopharmaceuticals Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 39: Global: Biopharmaceuticals Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 40: Global: Healthcare Cold Chain Logistic Services Market by Segment (in %), 2023 & 2032
• Figure 41: Global: Healthcare Cold Chain Transportation Services Market (in Billion US$), 2018-2023
• Figure 42: Global: Healthcare Cold Chain Transportation Services Market: Breakup by Transportation Mode (in %), 2023
• Figure 43: Global: Healthcare Cold Chain Transportation Services Market Forecast (in Billion US$), 2024-2032
• Figure 44: Global: Healthcare Cold Chain Packaging Services Market (in Billion US$), 2018-2023
• Figure 45: Global: Healthcare Cold Chain Packaging Services Market: Breakup by Packaging Type (in %), 2023
• Figure 46: Global: Healthcare Cold Chain Packaging Services Market Forecast (in Billion US$), 2024-2032
• Figure 47: Global: Healthcare Cold Chain Instrumentation Services Market (in Billion US$), 2018-2023
• Figure 48: Global: Healthcare Cold Chain Instrumentation Services Market: Breakup by Instrumentation Type (in %), 2023
• Figure 49: Global: Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2024-2032
• Figure 50: Global: Healthcare Cold Chain Logistic Spending by Region (in US$ Billion), 2020, 2023, 2024, 2026 and 2032
• Figure 51: North America: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 52: North America: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 53: Europe: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 54: Europe: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 55: Asia Pacific: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 56: Asia Pacific: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 57: Rest of the World: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 58: Rest of the World: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 59: Global: Healthcare Cold Chain Logistics Industry: SWOT Analysis
• Figure 60: Global: Healthcare Cold Chain Logistics Industry: Value Chain Analysis
• Figure 61: Global: Healthcare Cold Chain Logistics Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Healthcare Cold Chain Products Market: Breakup by Segment (in Billion US$), 2018-2023
• Table 2: Global: Healthcare Cold Chain Products Market Forecast: Breakup by Segment (in Billion US$), 2024-2032
• Table 3: Global: Biopharmaceutical Market: Sales by Class (in Billion US$), 2018-2023
• Table 4: Global: Biopharmaceutical Market Forecast: Sales by Class (in Billion US$), 2024-2032
• Table 5: Stability of Various Biopharmaceuticals at Room Temperature
• Table 6: Complexity of the Manufacturing Process Involved with Biopharmaceuticals and Small Molecule Drugs
• Table 7: Temperature Stability of Global: Biopharmaceutical Market Forecast- Sales by Class (in Billion US$), 2024-2032
• Table 8: The Effect of Temperature Excursions on the Usability of Vaccines
• Table 9: Ideal Storage Temperatures for Clinical Trial Materials
• Table 10: Various Regulations on Healthcare Cold Chain Logistic Requirements
• Table 11: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
• Table 12: Dry Ice Containers
• Table 13: Refrigerated Shipping Containers with Gel Packs
• Table 14: Cold Chain Logistics: Comparison Matrix for Transport Modes